Generation of Marfan Syndrome and Fontan Cardiovascular Models Using Patient-specific Induced Pluripotent Stem Cells
NCT02815072 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2016-06-28
Summary
Medical researchers of National Heart Centre Singapore will carry out a state-of-the-art study that examines the possibility of changing patients' own cells into multi-functional and potent stem cells called iPS cells. These iPS cells can subsequently give rise to functional cardiac cells (myocytes) and other cardiovascular cells which might give further clues into the manifestation of the structural heart disease. This study involves blood sample collection for pre-screening and skin biopsies to establish skin cell culture.
Conditions
- Marfan's Syndrome
Interventions
- OTHER
-
Skin biopsy
A sample of skin (approximately 0.5cm x 0.5cm) from inner thigh area. The skin biopsy will be conducted and completed with a single stitch to close the wound under local anaesthesia to minimise any discomfort. The skin biopsy will be taken by the medical doctor trained in biopsy collection. The tissue sample will be processed and cells will be grown out of them under appropriate conditions. These cells will only be used for laboratory experiments that include experimental transplantation models and laboratory bench-top research.
Sponsors & Collaborators
-
National Heart Centre Singapore
lead OTHER
Principal Investigators
-
Ju Le Tan, MBBS · National Heart Centre Singapore
Eligibility
- Min Age
- 21 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2017-05-31
- Completion
- 2017-05-31
Countries
- Singapore
Study Locations
More Related Trials
-
Autologous Transplantation of Bone Marrow Mononuclear Stem-Cells for Dilated Cardiomyopathy
NCT00743639 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Mesenchymal Stem Cells for Idiopathic Dilated Cardiomyopathy
NCT01957826 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)
NCT06464588 ·Status: RECRUITING ·Phase: PHASE1
-
Cell Therapy in Dilated Cardiomyopathy: Observational Study
NCT00612911 ·Status: TERMINATED
-
Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy
NCT01739777 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Progenitor Cell Therapy in Dilative Cardiomyopathy
NCT00284713 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF)
NCT00203203 ·Status: COMPLETED ·Phase: PHASE1
-
Allogeneic Stem Cell Therapy in Heart Failure
NCT03092284 ·Status: COMPLETED ·Phase: PHASE2
-
Intracoronary Autologous Mesenchymal Stem Cells Implantation in Patients With Ischemic Dilated Cardiomyopathy
NCT01720888 ·Status: UNKNOWN ·Phase: PHASE2
-
Intracoronary or Intravenous Infusion Human Wharton' Jelly-derived Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy
NCT02368587 ·Status: UNKNOWN ·Phase: PHASE2
-
Umbilical Cord Mesenchymal Stem Cell Improve Cardiac Function on ST-elevation Myocardial Infarction (STEMI) Patients
NCT05935423 ·Status: UNKNOWN ·Phase: PHASE3
-
Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC)
NCT02293603 ·Status: UNKNOWN ·Phase: PHASE1
-
The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF)
NCT03180450 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Stem Cell Therapy in Non-IschEmic Non-treatable Dilated CardiomyopathiEs II: a Pilot Study
NCT03797092 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Allogeneic iPSC-derived Cardiomyocyte Therapy in Patients With Worsening Ischemic Heart Failure
NCT05566600 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Autologous Stem Cells in Pediatric Patients With Dilated Cardiomyopathy
NCT01504594 ·Status: SUSPENDED ·Phase: PHASE1
-
Safety and Efficacy of Adipose Derived Stem Cells for Non-Ischemic Congestive Heart Failure
NCT01502501 ·Status: WITHDRAWN ·Phase: NA
-
Use of Bone Marrow Derived Stem Cell and G-CSF With Circulatory Assistance in the Treatment of DCM
NCT03572660 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients With Idiopathic Dilated Cardiomyopathy and Heart Failure.
NCT02033278 ·Status: TERMINATED ·Phase: PHASE2
-
Stem Cell Therapy to Improve Myocardial Function in Patients Undergoing Coronary Artery Bypass Grafting (CABG)
NCT00395811 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Evaluation of Circulating Levels of Adult Stem Cells in the Peripheral Blood of Patients With Acute Decompensated Heart Failure and Following Stabilization, in Comparison With Healthy Volunteers
NCT01027403 ·Status: COMPLETED
-
Study of Autologous Bone Marrow Derived Mononuclear Cells for Treatment of Ebstein Anomaly
NCT02914171 ·Status: COMPLETED ·Phase: PHASE1
-
Stem Cell Injection to Treat Heart Damage During Open Heart Surgery
NCT01557543 ·Status: TERMINATED ·Phase: PHASE1
-
Stem Cell Study for Patients With Heart Failure
NCT00346177 ·Status: WITHDRAWN ·Phase: PHASE2
-
Stem Cell Therapy in Patients With Severe Heart Failure & Undergoing Left Ventricular Assist Device Placement
NCT00869024 ·Status: COMPLETED ·Phase: PHASE1/PHASE2